Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice

Journal of General Virology

Volumn 85, Issue 8, 2004, Pages 2339-2346

  Yoshikawa, Tomoki ^a,b   Matsuo, Keiko ^a   Matsuo, Kazutoshi ^c   Suzuki, Yujiro ^d   Nomoto, Akio ^b   Tamura, Shin Ichi ^a,e   Kurata, Takeshi ^a   Sata, Tetsutaro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL VETERINARY ASSAY LABORATORY   (Japan)

^d KITASATO INSTITUTE   (Japan)

^e Osaka University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY; INFLUENZA VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CORRELATION ANALYSIS; FEMALE; IMMUNE RESPONSE; INFECTION RESISTANCE; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MOUSE; NONHUMAN; NOSE SECRETION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS PARTICLE; ANIMAL; BAGG ALBINO MOUSE; ELECTRON MICROSCOPY; GENE DOSAGE; GENETICS; IMMUNIZATION; IMMUNOLOGY; NOSE MUCOSA; ORTHOMYXOVIRUS INFECTION; POLYMERASE CHAIN REACTION; VIROLOGY;

INFLUENZA VIRUS;

ANIMALS; ANTIBODIES, VIRAL; ANTIGEN-ANTIBODY COMPLEX; FEMALE; GENE DOSAGE; GENOME, VIRAL; IMMUNIZATION; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; NASAL MUCOSA; ORTHOMYXOVIRIDAE INFECTIONS; POLYMERASE CHAIN REACTION;

EID: 4043121096     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.79892-0     Document Type: Article

References (32)

1. Armstrong, S. J. & Dimmock, N. J. (1992). Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited. J Virol 66, 3823-3832.
2. Asahi, Y., Yoshikawa, T., Watanabe, I. & 16 other authors (2002). Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J Immunol 168, 2930-2938.
3. Cone, R. A. (1999). Mucus. In Mucosal Immunology, pp. 43-64. Edited by P. L. Ogra, M. E. Lamm, J. R. McGhee, J. Mestecky, W. Strober & J. Binenestock. San Diego: Academic Press.
4. Corthier, G. & Vannier, P. (1983). Production of coproantibodies and immune complexes in piglets infected with rotavirus. J Infect Dis 147, 293-296.
5. Couch, R. B. & Kasel, J. A. (1983). Immunity to influenza in man. Annu Rev Microbiol 37, 529-549.
6. Drake, J. W. (1993). Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A 90, 4171-4175.
7. + T cells in primary and secondary influenza pneumonia. Immunity 8, 683-691.
8. Lamb, R. A. & Krug, R. M. (2001). Orthomyxoviridae: the viruses and their replication. In Virology, pp. 1397-1445. Edited by B. N. Fields, P. M. Howley & D. M. Knipe. Philadelphia: Lippincott-Raven.
9. Liew, F. Y., Russell, S. M., Appleyard, G., Brand, C. M. & Beale, J. (1984). Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol 14, 350-356.
10. McMichael, A. (1994). Cytotoxic T lymphocytes specific for influenza virus. Curr Top Microbiol Immunol 189, 75-91.
11. Mestecky, J. & McGhee, J. R. (1987). Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 40, 153-245.
12. Murphy, B. R. (1994). Mucosal immunity to viruses. In Handbook of Mucosal Immunology, pp. 333-343. Edited by P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee & J. Binenestock. San Diego: Academic Press.
13. Murphy, B. R. & Clements, M. L. (1989). The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microbiol Immunol 146, 107-116.
14. Outlaw, M. C. & Dimmock, N. J. (1990). Mechanisms of neutralizatin of influenza virus on mouse tracheal epithelial cells by mouse monoclonal polymeric IgA and polyclonal IgM directed against the viral haemagglutinin. J Gen Virol 71, 69-76.
15. Outlaw, M. C. & Dimmock, N. J. (1991). Insights into neutralization of animal viruses gained from study of influenza virus. Epidemiol Infect 106, 205-220.
16. Peng, X. X., Zhu, H., Zhang, J. Y. & Wang, S. Y. (2001). Analysis of HCV-IG isotype complexes by a novel immuno-capture RT-PCR method. Scand J Immunol 54, 409-413.
17. Phelan, M. A., Mayner, R. E., Bucher, D. J. & Ennis, F. A. (1980). Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J Biol Stand 8, 233-242.
18. Reinacher, M. & Weiss, E. (1975). Electron microscopical study of initial and final stages of fowl plague virus-replication in chick embryo cells. Arch Virol 49, 187-197.
19. Renegar, K. B., Jackson, G. D. & Mestecky, J. (1998). In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J Immunol 160, 1219-1223.
20. Schulman, J. L. & Kilbourne, E. D. (1965). Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. J Bacteriol 89, 170-174.
21. Shiraki, K., Mukai, T., Okuno, T., Yamanishi, K. & Takahashi, M. (1991). Physicochemical characterization of human herpes virus 6 infectivity. J Gen Virol 72, 169-172.
22. Shugars, D. C. (1999). Endogenous mucosal antiviral factors of the oral cavity. J Infect Dis 179 (Suppl. 3), S431-S435.
23. Tamura, S., Ito, Y., Asanuma, H., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C. & Kurata, T. (1992). Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immunol 149, 981-988.
24. Tamura, S., Miyata, K., Matsuo, K., Asanuma, H., Takahashi, H., Nakajima, K., Suzuki, Y., Aizawa, C. & Kurata, T. (1996). Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J Immunol 156, 3892-3900.
25. Tobita, K. (1975). Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B viruses. Med Microbiol Immunol 162, 23-27.
26. Tobita, K., Sugiura, A., Enomote, C. & Furuyama, M. (1975). Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol 162, 9-14.
27. van Elden, L. J., Nijhuis, M., Schipper, P., Schuurman, R. & van Loon, A. M. (2001). Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol 39, 196-200.
28. Watson, D. H., Russell, W. C. & Wildy, P. (1963). Electron microscopic particle counts on herpes virus using the phosphotungstate negative staining technique. Virology 19, 250-260.
29. + T cells persist in the upper respiratory tract following influenza virus infection. J Immunol 167, 3293-3299.
30. Wilson, R., Alton, E., Rutman, A., Higgins, P., Al Nakib, W., Geddes, D. M., Tyrrell, D. A. & Cole, P. J. (1987). Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis 70, 272-279.
31. Yap, K. L. & Ada, G. L. (1978). Cytotoxic T cells in the lungs of mice infected with an influenza A virus. Scand J Immunol 7, 73-80.
32. Yetter, R. A., Lehrer, S., Ramphal, R. & Small, P. A., Jr (1980). Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect Immun 29, 654-662.